BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16522231)

  • 1. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An eighteen-year study on phenylketonuria].
    Yu WM; Xu L; Li XW; He C; Shen M; Zhang ZX; Jin YY; Zhou ZS; Qiao F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):218-22. PubMed ID: 12905726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global and regional volume changes in the brains of patients with phenylketonuria.
    Pérez-Dueñas B; Pujol J; Soriano-Mas C; Ortiz H; Artuch R; Vilaseca MA; Campistol J
    Neurology; 2006 Apr; 66(7):1074-8. PubMed ID: 16606920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C; Hanley WB; Rudner HL
    Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
    Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
    Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria: MR imaging of the brain with clinical correlation.
    Pearsen KD; Gean-Marton AD; Levy HL; Davis KR
    Radiology; 1990 Nov; 177(2):437-40. PubMed ID: 2217781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)].
    Knoll E; Wehle E; Thalhammer O
    Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients.
    Ding XQ; Fiehler J; Kohlschütter B; Wittkugel O; Grzyska U; Zeumer H; Ullrich K
    J Magn Reson Imaging; 2008 May; 27(5):998-1004. PubMed ID: 18425822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
    Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria.
    Hasselbalch S; Knudsen GM; Toft PB; Høgh P; Tedeschi E; Holm S; Videbaek C; Henriksen O; Lou HC; Paulson OB
    Pediatr Res; 1996 Jul; 40(1):21-4. PubMed ID: 8798240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.
    Waisbren SE; Mahon BE; Schnell RR; Levy HL
    Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging and proton magnetic resonance spectroscopy of the brain in the diagnostic evaluation of developmental delay.
    Verbruggen KT; Meiners LC; Sijens PE; Lunsing RJ; van Spronsen FJ; Brouwer OF
    Eur J Paediatr Neurol; 2009 Mar; 13(2):181-90. PubMed ID: 18579422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR evidence of long T2 water in pathological white matter.
    Laule C; Vavasour IM; Mädler B; Kolind SH; Sirrs SM; Brief EE; Traboulsee AL; Moore GR; Li DK; MacKay AL
    J Magn Reson Imaging; 2007 Oct; 26(4):1117-21. PubMed ID: 17896375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.